Literature DB >> 24753333

Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestation.

Graeme J Moffat1, Marc W Retter, Gayle Kwon, Mark Loomis, M Benjamin Hock, Colin Hall, Jeanine Bussiere, Elise M Lewis, Gary J Chellman.   

Abstract

Understanding species differences in the placental transfer of monoclonal antibodies is important to inform species selection for nonclinical safety assessment, interpret embryo-fetal changes observed in these studies, and extrapolate their human relevance. Data presented here for a fully human immunoglobulin G2 monoclonal antibody (IgG2X) revealed that, during organogenesis, in both the cynomolgus monkey (gestation day 35 [gd35]) and the rat (gd10) the extent of IgG2X placental transfer (approximately 0.5% maternal plasma concentration, MPC) was similar to the limited published human data for endogenous IgG. At this early gestational stage, IgG2X placental transfer was approximately 6-fold higher in the rabbit (gd10). By the end of organogenesis, rat embryonic plasma concentrations (gd16) exceeded those in the cynomolgus monkey (gd50) by approximately 3-fold. These data suggest that relative to the cynomolgus monkey, the rabbit (and to a lesser extent the rat) may overestimate potential harmful effects to the human embryo during this critical period of development. Beyond organogenesis, fetal IgG2X plasma concentrations increased approximately 10-fold early in the second trimester (gd50-70) in the cynomolgus monkey and remained relatively unchanged thereafter (at approximately 5% MPC). Late gestational assessment was precluded in rabbits due to immunogenicity, but in rats, fetal IgG2X plasma concentrations increased more than 6-fold from gd16 to gd21 (reaching approximately 15% MPC). In rats, maternal exposure consistent with that achieved by ICH S6(R1) high-dose selection criteria resulted in embryonic plasma concentrations, reaching pharmacologically relevant levels during organogenesis. Furthermore, dose proportional exposure in both mothers and embryos indicated that this was unlikely to occur at the lower therapeutic dose levels used in humans.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  human risk; monoclonal antibody; placental transfer; species differences

Mesh:

Substances:

Year:  2014        PMID: 24753333     DOI: 10.1002/bdrb.21105

Source DB:  PubMed          Journal:  Birth Defects Res B Dev Reprod Toxicol        ISSN: 1542-9733


  5 in total

1.  Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development.

Authors:  Wendy G Halpern; Mehrdad Ameri; Christopher J Bowman; Michael R Elwell; Michael L Mirsky; Julian Oliver; Karen S Regan; Amera K Remick; Vicki L Sutherland; Kary E Thompson; Claudine Tremblay; Midori Yoshida; Lindsay Tomlinson
Journal:  Toxicol Pathol       Date:  2016-05-27       Impact factor: 1.902

2.  An open-label study in healthy men to evaluate the risk of seminal fluid transmission of denosumab to pregnant partners.

Authors:  Winnie Sohn; Edward Lee; Martin K Kankam; Ogo Egbuna; Graeme Moffat; Jeanine Bussiere; Desmond Padhi; Eric Ng; Sandeep Kumar; J Greg Slatter
Journal:  Br J Clin Pharmacol       Date:  2015-12-05       Impact factor: 4.335

3.  Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes.

Authors:  Bence Szikora; László Hiripi; Balázs Bender; Imre Kacskovics; Attila Iliás
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

4.  Maternal Tn Immunization Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats Through Suppression of Oxidative Stress and Inflammation.

Authors:  Chung-Ming Chen; Jaulang Hwang; Hsiu-Chu Chou
Journal:  Front Immunol       Date:  2019-04-04       Impact factor: 7.561

Review 5.  Animal Models for In Vivo Lactation Studies: Anatomy, Physiology and Milk Compositions in the Most Used Non-Clinical Species: A Contribution from the ConcePTION Project.

Authors:  Domenico Ventrella; Nurit Ashkenazi; Alberto Elmi; Karel Allegaert; Camilla Aniballi; Anthony DeLise; Patrick John Devine; Anne Smits; Lilach Steiner; Monica Forni; Michele Bouisset-Leonard; Maria Laura Bacci
Journal:  Animals (Basel)       Date:  2021-03-05       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.